The Commercial Success of Cancer Therapeutic Antibodies

"Analytical Tool - The Commercial Success of Cancer Therapeutic Antibodies" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in antibody R&D and business development in oncology. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies and their progress. This tool provides you with an immense amount of information structured and analyzed to assist you in your work. It is designed to assist you in finding right partners, optimizing your licensing deals, wisely choosing which projects give you the best competitive advantage, and assuring you that your decisions have been based on the most accurate, validated and precise facts available.

Included in this advantageous package are two products already appreciated by many of our customers - The Commercial Success of Cancer Therapeutic Antibodies - The Formation of a Second Wave and Antibodies in Oncology: Drug Pipeline Update 2007*.

The Package Includes

A progress analysis on current and emerging drugs

Information on most oncology companies active in antibody R&D

Information on key oncology industry related antibody projects

Data from most important clinical trials

Information on early developmental stage projects

Possibility of performing advanced searches suited to your individual needs

This Tool will Assist You in:

Tracking cutting edge companies, therapies and new technologies

Rapid identification of partners & competitors

Laying down a comprehensive framework for further analysis of the field

Producing presentations surrounding the development of antibody therapeutics in oncology

Identifying emerging cancer antibody products & key areas of pharmaceutical R&D

*BioSeeker’s CD-ROM searchable database reflects the most recent advances in the field of cancer antibody drug development, in order to help you perform your own analysis, go back to the source data for in-depth information, and present the research and development in tables and graphs suited for your own specific purposes. A significant advantage with BioSeeker Group CD-ROM searchable databases is that they provide you with well-structured information. Each pipeline drug/project has been carefully defined and classified in categories and subcategories. The main categories include therapy type, effect, mechanism of action (molecular target), indication, stage of development etc. These categories are further organized and classified in sub-categories. In comparison with other available databases, BioSeeker Group’s CD-ROM searchable databases give better overview and specific search capabilities.

July 2006 CD-ROM
Price: $4,795.00 / GBP2,397.50